Feb 27, 2024 / 09:30PM GMT
Operator
Good afternoon, everyone. My name is Bo, and I will be your conference operator today. At this time, I would like to welcome everyone to the Vaxcyte fourth-quarter and full-year 2023 financial results conference call. (Operator Instructions) And just a reminder, today's call is being recorded.
Now at this time, I'll turn things over to Mr. Andrew Guggenheim, President and Chief Financial Officer of Vaxcyte. Please go ahead, sir.
Andrew Guggenhime - Vaxcyte Inc - Chief Financial Officer, Senior Vice President
Thank you, operator, and good afternoon, everyone. I'd like to welcome you to Vaxcyte's earnings conference call to discuss our 2023 results and to provide a business update. I'm joined today by our Chief Executive Officer, Grant Pickering, and our Executive Vice President and Chief Operating Officer, Jim Wassil.
Earlier this afternoon, we issued a news release announcing our results. Copies of this and our other news releases for the corporate presentation and SEC filings can be found in the Investors and Media section of our website.
Q4 2023 Vaxcyte Inc Earnings Call Transcript
Feb 28, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers